Cargando…

The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients

BACKGROUND: MicroRNA expression signatures can promote personalised care for non-small cell lung cancer (NSCLC) patients. Our aim was to evaluate the previously unexplored prognostic potential of miR-197, a key oncogenic molecule for NSCLC. METHODS: Total RNA isolation (n=124 NSCLC and n=21 tumour-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mavridis, K, Gueugnon, F, Petit-Courty, A, Courty, Y, Barascu, A, Guyetant, S, Scorilas, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453672/ https://www.ncbi.nlm.nih.gov/pubmed/25867273 http://dx.doi.org/10.1038/bjc.2015.119

Ejemplares similares

OMCD: OncomiR Cancer Database
por: Sarver, Aaron L., et al.
Publicado: (2018)

miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma
por: Liang, Hongwei, et al.
Publicado: (2016)

miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer
por: Li, Yan, et al.
Publicado: (2019)

miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4
por: Liu, Yanqing, et al.
Publicado: (2016)

OncomiR Addiction Is Generated by a miR-155 Feedback Loop in Theileria-Transformed Leukocytes
por: Marsolier, Justine, et al.
Publicado: (2013)

MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression
por: de Melo Maia, Beatriz, et al.
Publicado: (2016)

Author Correction: miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma
por: Liang, Hongwei, et al.
Publicado: (2021)

Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level
por: Wang, Dong, et al.
Publicado: (2018)

OncomiR-17-5p: alarm signal in cancer?
por: Bobbili, Madhusudhan Reddy, et al.
Publicado: (2017)

miR-3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression
por: Yang, Xiu-Hua, et al.
Publicado: (2018)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma
por: Janiszewska, Joanna, et al.
Publicado: (2015)

A structural map of oncomiR-1 at single-nucleotide resolution
por: Chakraborty, Saikat, et al.
Publicado: (2017)

Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
por: Das, Ani V., et al.
Publicado: (2015)

miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis
por: Seashols-Williams, S. J., et al.
Publicado: (2016)

Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis
por: Barnaś, Edyta, et al.
Publicado: (2023)

Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis
por: Budd, William T., et al.
Publicado: (2015)

Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
por: Gilles, Maud-Emmanuelle, et al.
Publicado: (2019)

OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1
por: Boces-Pascual, Clara, et al.
Publicado: (2021)

The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b
por: Ma, Qiang, et al.
Publicado: (2015)

The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients
por: Avgeris, M, et al.
Publicado: (2013)

New insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR
por: Perez‐Añorve, Isidro X., et al.
Publicado: (2019)

OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers
por: Monroig-Bosque, Paloma del C., et al.
Publicado: (2018)

Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer
por: Dhar, Swati, et al.
Publicado: (2015)

OncomiRs: the discovery and progress of microRNAs in cancers
por: Cho, William CS
Publicado: (2007)

MiR-320e is a novel prognostic biomarker in colorectal cancer
por: Perez-Carbonell, L, et al.
Publicado: (2015)

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma
por: Gattolliat, C-H, et al.
Publicado: (2011)

Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?
por: Jeang, Kuan-Teh
Publicado: (2010)

MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
por: Banno, Kouji, et al.
Publicado: (2014)

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
por: Huh, J H, et al.
Publicado: (2013)

miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer
por: Zhang, J, et al.
Publicado: (2012)

miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions
por: Grignol, V, et al.
Publicado: (2011)

EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas
por: Nourmohammadi, Fatemeh, et al.
Publicado: (2022)

OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer
por: Lin, Min-Ying, et al.
Publicado: (2021)

miR-30e* is an independent subtype-specific prognostic marker in breast cancer
por: D'Aiuto, F, et al.
Publicado: (2015)

Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma
por: Wang, Cong, et al.
Publicado: (2016)

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
por: Xu, Y, et al.
Publicado: (2012)

MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion
por: Falkenberg, N, et al.
Publicado: (2013)

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours
por: Gits, C M M, et al.
Publicado: (2013)

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
por: Yoshino, H, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qldk25gr6bbmglsh8g35cg138h